In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
Vascular smooth muscle cells infiltrate and further stabilize the site, and a new endothelium is eventually generated
A vial that left the manufacturer at 20C may have spent 1248 hours at ambient temperature during customs clearance, warehouse transfer, or final-mile delivery
11.2 Inhibitors of phagocyte RS production Phagocytes (such as neutrophils and macrophages) have an important role as the first line of defense of an organism against pathogens
Observational studies of patients on GLP-1 medications post-cholecystectomy show that nausea, constipation, and diarrhea occur at similar or sometimes slightly lower rates compared to gallbladder-intact cohorts
